Clorazepate dipotassium

This classification denotes a benzodiazepine with the molecular formula C16H10ClN2O3.2K.HO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 63FN7G03XY, chemically known as 7-chloro-2,3-dihydro-2,2-dihydroxy-5-phenyl-1h-1,4-benzodiazepine-3-carboxylic acid but more generally known as clorazepate dipotassium, which bears US NIH Compound Identifier 2809. European Medicines Agency schedules Clorazepate dipotassium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13397MIG. The term DIPOTASSIUM CLORAZEPATE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 21 No. 12 1967, List 7). World Health Organization schedules clorazepate dipotassium in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations, for tariff and trade purposes, schedule clorazepate dipotassium under HS 29339100 and SITC 51577. As of Q4 2014, CLORAZEPATE DIPOTASSIUM remains US FDA's Preferred Term for this commodity. Clorazepate dipotassium bears US NLM identifiers UMLS ID C0009033 and NCI Concept Code C47459. SMILES: C1CCC(CC1)C2=NC(C(=O)NC3C2CC(CC3)CL)C(=O)[O-].[OH-].[K+].[K+].